leuprolide (Soligenix)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameleuprolide (Soligenix)
Drug Alias Nameluteinizing hormone-releasing hormone (DOR BioPharma)oral LHRH (DOR BioPharma)LHRH (DOR Biopharma)leuprolide (DOR BioPharma)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGonadotropin-releasing hormone receptor agonists
TargetsGonadotropin-releasing hormone receptor
Therapy Area/IndicationsEndometriosisProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSoligenix Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSoligenix Inc
Active IndicationsN/A
Inactive IndicationsEndometriosisProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A